RDHL ▼ -4.5% - RedHill Biopharma Ltd. $RDHL RDHL - RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities RedHill Biopharma sold Talicia® to Apotex for $18 million upfront plus potential milestone payments, a divestment aimed at funding the company's strategic priorities. Despite the stated goal of fueling growth opportunities, the stock declined 4.5%, suggesting investors may view the sale price as modest or have concerns about losing revenue from the divested asset. 31-AUG-2026 07:01 AM ET